Evidence map›Paper›PMID 34410364›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2022

The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey.

Stefan Simovic, Rui Providencia, Sergio Barra, Bratislav Kircanski, Jose M Guerra, Giulio Conte, David Duncker, Eloi Marijon, Ante Anic, Serge Boveda

Open access · bronzeAbstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. Comprehensive vs. standard remote monitoring of cardiac resynchronization devices in heart failure patients: results of the ECOST-CRT study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Conduction system pacing: where are we today?Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023
    Article
  13. The digital journey: 25 years of digital development in electrophysiology from an Europace perspective.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Review
  14. Remote monitoring of cardiac implantable electronic devices and disease management.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  15. Article
  16. HeartLogic™: real-world data-efficiency, resource consumption, and workflow optimization.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 9 countries.

Stefan SimovicDepartment of Internal Medicine, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia.ORCID 0000-0003-0911-2028
Rui ProvidenciaSt Bartholomew's Hospital, Barts Heart Centre, Barts Health NHS Trust, London, UK.
Sergio BarraCardiology Department, Hospital da Luz Arrabida, V. N. Gaia, Portugal.ORCID 0000-0003-4064-3767
Bratislav KircanskiUniversity Clinical Centre of Serbia, Pacemaker Centre, Belgrade, Serbia.
Jose M GuerraDepartment of Cardiology, Hospital de la Santa Creu i Sant Pau, Universidad Autonoma de Barcelona, CIBERCV, Barcelona, Spain.
Giulio ConteCardiology Department, Fondazione Cardiocentro Ticino, Lugano, Switzerland.ORCID 0000-0003-2248-3456
David DunckerHannover Heart Rhythm Center, Department of Cardiology and Angiology, Hannover Medical School, Hannover,  Germany.ORCID 0000-0003-2996-6338
Eloi MarijonUniversity of Paris, Paris, France.ORCID 0000-0001-7227-3428
Ante AnicDepartment for Cardiovascular diseases, University Hospital Center Split, Split, Croatia.ORCID 0000-0002-6864-3999
Serge BovedaInstitut National de la Sante et de la Recherche Medicale U970, 75908 Paris Cedex 15, France.ORCID 0000-0002-8425-3544
Inserm · FREpatocentro Ticino · CHMedizinische Hochschule Hannover · DEPapworth Hospital NHS Foundation Trust · GBSt Bartholomew's Hospital · GBUniversitat Autònoma de Barcelona · ESUniversity of Belgrade · RSUniversity of Kragujevac · RSUniversity of Split · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is unclear to what extent the COVID-19 pandemic has influenced the use of remote monitoring (RM) of cardiac implantable electronic devices (CIEDs). The present physician-based European Heart Rhythm Association (EHRA) survey aimed to assess the influence of the COVID-19 pandemic on RM of CIEDs among EHRA members and how it changed the current practice. The survey comprised 27 questions focusing on RM use before and during the pandemic. Questions focused on the impact of COVID-19 on the frequency of in-office visits, data filtering, reasons for initiating in-person visits, underutilization of RM during COVID-19, and RM reimbursement. A total of 160 participants from 28 countries completed the survey. Compared to the pre-pandemic period, there was a significant increase in the use of RM in patients with pacemakers (PMs) and implantable loop recorders (ILRs) during the COVID-19 pandemic (PM 24.2 vs. 39.9%, P = 0.002; ILRs 61.5 vs. 73.5%, P = 0.028), while there was a trend towards higher utilization of RM for cardiac resynchronization therapy-pacemaker (CRT-P) devices during the pandemic (44.5 vs. 55%, P = 0.063). The use of RM with implantable cardioverter-defibrillators (ICDs) and CRT-defibrillator (CRT-D) did not significantly change during the pandemic (ICD 65.2 vs. 69.6%, P = 0.408; CRT-D 65.2 vs. 68.8%, P = 0.513). The frequency of in-office visits was significantly lower during the pandemic (P < 0.001). Nearly two-thirds of participants (57 out of 87 respondents), established new RM connections for CIEDs implanted before the pandemic with 33.3% (n = 29) delivering RM transmitters to the patient's home address, and the remaining 32.1% (n = 28) activating RM connections during an in-office visit. The results of this survey suggest that the crisis caused by COVID-19 has led to a significant increase in the use of RM of CIEDs.

Indexed as

COVID-19Defibrillators, ImplantablePhysiciansHumansPandemicsSARS-CoV-2Surveys and QuestionnairesCardiac implantable electronic devicesCOVID-19EHRA surveyRemote monitoring

Identifiers

PMID34410364
PMCPMC8499732
OpenAlexW3194397701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.